VerifiedEvidence: highv1.0.0

Dose Response

The relationship between the amount of a drug given and the magnitude of its resulting biological or clinical effect.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept


Theoretically, Dose?Response describes the quantitative relationship between the dose of an intervention or exposure and the magnitude or probability of the resulting biological or clinical effect. It is founded on pharmacology, toxicology and receptor theory and provides the basis for identifying therapeutic efficacy, toxicity and optimal dosing. In health economics, dose?response relationships inform comparative effectiveness, treatment optimisation, cost-effectiveness modelling and value assessment of pharmaceutical interventions.

Mathematically, dose?response relationships are represented using nonlinear functions that characterise how response changes with increasing dose. The most widely recognised mathematical framework is the sigmoid Emax (Hill) model, which describes the asymptotic increase in effect towards a maximum response. Simpler linear, log-linear or logistic models may also be used where appropriate, depending on the underlying biological mechanism and available data.

In practice, dose?response relationships are estimated from preclinical experiments, dose-finding studies and clinical trials using nonlinear regression or maximum likelihood estimation. The estimated parameters are used to identify minimum effective doses, optimal therapeutic doses and toxicity thresholds. In health economics, these estimates are incorporated into decision models to predict health outcomes, adverse events, resource utilisation and cost-effectiveness across alternative dosing strategies.

Purpose


Used to quantify the relationship between dose and therapeutic or adverse response, supporting dose selection, regulatory evaluation and health economic modelling of pharmaceutical interventions.


Mathematical Formulae

Primary Formula

E = E? + (Emax ? D?) / (EC??? + D?)

Supporting Formulae

Linear dose?response model:

E = ?? + ??D

Simple Emax model:

E = E? + (Emax ? D) / (EC?? + D)

Logistic response model:

P(Response) = 1 / (1 + e?(?? + ??D))

Related Mathematical Methods

  • Nonlinear Regression
  • Emax Model
  • Hill Equation
  • Logistic Regression
  • Maximum Likelihood Estimation
  • Pharmacodynamic Modelling

Example

A new medicine has an estimated maximum treatment effect of 40 percentage points above baseline, an EC?? of 50 mg and a Hill coefficient of 1.

For a 100 mg dose:

E = 0 + (40 ? 100) / (50 + 100)

E = 26.7

The predicted treatment effect is approximately 26.7 percentage points above baseline, indicating that increasing the dose beyond 100 mg would provide progressively smaller additional benefits as the maximum response is approached.


Excel Implementation

FunctionExample FormulaHealth Economics Application
POWER=Dose^HillCalculates the Hill function component of the dose?response model.
SUM=E0+(Emax*POWER(Dose,Hill))/(POWER(EC50,Hill)+POWER(Dose,Hill))Estimates expected treatment response at a specified dose.
Solver Add-inMinimise residual sum of squares by changing Emax, EC50 and HillEstimates dose?response parameters using nonlinear optimisation.
LOGEST=LOGEST(ResponseRange,DoseRange)Fits exponential relationships where appropriate.
LINEST=LINEST(ResponseRange,DoseRange)Estimates parameters for linear dose?response models.

VBA (Optional)

VBA can automate nonlinear estimation of dose?response models across multiple studies and generate predicted response curves for economic evaluation.


Sources

  • Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications.
  • Holford NHG, Sheiner LB. Understanding the dose?effect relationship: clinical application of pharmacokinetic?pharmacodynamic models.
  • Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications.
  • Ette EI, Williams PJ. Pharmacokinetics in Drug Development.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes.

Frequently Asked Questions (6)

  • What is dose response?

    The relationship between the amount of a drug given and the magnitude of its resulting biological or clinical effect.

    Source: Rowland & Tozer 2010

  • What relationship does dose response describe?

    Dose response describes the relationship between how much of a drug is given and how large an effect it produces, the fundamental link between dose and effect. Typically the effect grows as the dose rises, up to a point where it levels off, and mapping this curve shows how much drug is needed for a useful effect and where the gains stop. Understanding it underlies the setting of doses and the balance between benefit and harm, since harmful effects follow their own dose-response curves. How effect scales with dose is what it captures. Rowland and Tozer (2010) describe this.

    Source: Rowland & Tozer 2010

  • Why is the dose-response relationship important?

    The dose-response relationship is important because it shows how a drug's effect varies with dose, which is central to choosing a dose that achieves the desired effect without causing excessive harm, so understanding it guides appropriate dosing. So the dose-response relationship matters for determining doses, which is why it is studied, since knowing how effect changes with dose is necessary to select a dose that provides benefit while limiting toxicity, and understanding the relationship allows the balance between effect and side effects to be judged, making the dose-response relationship fundamental to using a drug effectively and safely at an appropriate dose.

    Source: Rowland & Tozer 2010

  • How does effect change with dose?

    Effect generally changes with dose in a characteristic way, often increasing as the dose rises up to a point, after which further increases may produce little additional effect or increasing toxicity; the exact shape of the relationship varies between drugs. So effect typically increases with dose up to a limit, which is why the relationship is characterised, since understanding how effect rises with dose and where it levels off or where toxicity increases is important for dosing, and knowing the shape of the dose-response relationship for a drug allows an appropriate dose to be chosen that achieves adequate effect without unnecessary increases that add toxicity rather than benefit.

    Source: Rowland & Tozer 2010

  • How is the dose-response relationship used in determining doses?

    The dose-response relationship is used in determining doses by identifying the dose that produces the desired effect while keeping toxicity acceptable, using knowledge of how effect and side effects change with dose to select an appropriate dose. So the dose-response relationship guides dose selection, which is why it is central to dosing, since choosing a dose requires knowing how much effect a given amount produces and how toxicity rises with dose, and using the relationship allows a dose to be chosen that balances benefit and harm, making dose-response information the basis for setting doses that achieve the intended effect at acceptable risk.

    Source: Rowland & Tozer 2010

  • How does the dose-response relationship relate to drug safety?

    The dose-response relationship relates to drug safety because both the beneficial effect and the toxicity of a drug typically vary with dose, so understanding the relationship helps identify a dose that provides benefit while keeping toxicity within acceptable limits. So the dose-response relationship informs safe dosing, which is why it is important for safety, since the margin between doses that produce benefit and those that cause harm depends on how effect and toxicity change with dose, and knowing the relationship allows a dose to be chosen that stays within a safe range, making dose-response understanding central to using a drug both effectively and safely.

    Source: Rowland & Tozer 2010

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 27 Apr 2026

Content version: 1.0.0

Canonical Identity

Term code
HE-PE-DT-013

Stable URI · Machine-readable · Resolvable · CC BY 4.0